Last reviewed · How we verify

Live attenuated influenza vaccine — Competitive Intelligence Brief

Live attenuated influenza vaccine (Live attenuated influenza vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology.

marketed Live attenuated vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Live attenuated influenza vaccine (Live attenuated influenza vaccine) — The University of Hong Kong. This vaccine contains live but weakened influenza viruses that replicate in the nasal mucosa to stimulate both mucosal and systemic immune responses without causing disease.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Live attenuated influenza vaccine TARGET Live attenuated influenza vaccine The University of Hong Kong marketed Live attenuated vaccine
Pentavalent rotavirus vaccine Pentavalent rotavirus vaccine Sanofi Pasteur, a Sanofi Company marketed Live attenuated vaccine
Bacille Calmette-Guérin (BCG) Bacille Calmette-Guérin (BCG) TASK Applied Science marketed Live attenuated vaccine / Immunotherapy Pattern recognition receptors (TLR2, TLR4, NOD2); non-specific immune activation
Bacillus Calmette-Guerin (BCG) Bacillus Calmette-Guerin (BCG) Massachusetts General Hospital marketed Live attenuated vaccine / Immunotherapy
Bacille Calmette Guerin (BCG) Bacille Calmette Guerin (BCG) Bandim Health Project marketed Live attenuated vaccine
Zoster Vaccine Live Zoster Vaccine Live Merck Sharp & Dohme LLC marketed Live attenuated vaccine Varicella-zoster virus (VZV)
Yellow fever vaccine, Institut Pasteur Yellow fever vaccine, Institut Pasteur University of Oxford marketed Live attenuated vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

  1. GlaxoSmithKline · 19 drugs in this class
  2. Merck Sharp & Dohme LLC · 11 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
  4. PATH · 5 drugs in this class
  5. Sanofi · 5 drugs in this class
  6. Bandim Health Project · 5 drugs in this class
  7. Centers for Disease Control and Prevention · 3 drugs in this class
  8. International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
  9. Beijing Center for Disease Control and Prevention · 2 drugs in this class
  10. Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Live attenuated influenza vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/live-attenuated-influenza-vaccine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: